Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 24, 2020 | Dog | Terrier - Bull - Staffordshire | Neomycin Sulfate;Tetracaine Hydrochlo... | Anal irritation; Pruritus; Dermatitis; Reddening of the skin; Skin scab; Leth... | Ongoing |
| Feb 16, 2020 | Cat | Domestic Shorthair | Bupivacaine | Injection site mucopurulent discharge; Injection site necrosis; Crust; Hair s... | Outcome Unknown |
| Feb 11, 2020 | Dog | Crossbred Canine/dog | Moxidectin | Hot spot (pyotraumatic dermatitis); Dermatitis | Ongoing |
| Feb 8, 2020 | Dog | Greyhound - Italian | Carprofen | Lethargy (see also Central nervous system depression in 'Neurological'); Hidi... | Ongoing |
| Feb 1, 2020 | Dog | Crossbred Canine/dog | Insulin Injectable Vial | Pruritus; Dermatitis; INEFFECTIVE, GLYCEMIC CONTROL | Ongoing |
| Jan 31, 2020 | Dog | Retriever - Golden | Fluralaner Chew Tablets | Itching; Chewing - pruritus (see also 'Oral cavity disorders'); Hot spot (pyo... | Ongoing |
| Jan 27, 2020 | Dog | Chihuahua | Fluralaner Chew Tablets | Alopecia; Localised rash; Lethargy (see also Central nervous system depressio... | Ongoing |
| Jan 25, 2020 | Dog | Pointing Dog - Italian Wire... | Fluralaner 13.64% Chew Tablets | Pruritus; Red eye; Erythema (for urticaria see Immune SOC); Hot spot (pyotrau... | Recovered/Normal |
| Jan 24, 2020 | Cat | Domestic Shorthair | Amoxicillin Trihydrate;Clavulanate Po... | Reddening of the skin; Moist dermatitis | Ongoing |
| Jan 22, 2020 | Dog | Mountain Dog - Bernese | Oclacitinib Maleate | Lack of efficacy - NOS; Licking; Skin inflammation NOS; Malodour; Anal irrita... | Ongoing |
| Jan 21, 2020 | Dog | Pointing Dog - German Short... | Desoxycorticosterone Pivalate | Lethargy (see also Central nervous system depression in 'Neurological'); Vomi... | Outcome Unknown |
| Jan 17, 2020 | Dog | Pug | Fluralaner Chew Tablets | Emesis (multiple); Diarrhoea; Lethargy (see also Central nervous system depre... | Recovered/Normal |
| Jan 17, 2020 | Dog | Mixed (Dog) | Sarolaner | Itching; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Jan 15, 2020 | Dog | Crossbred Canine/dog | Fluralaner Chew Tablets | Dermatitis; Anxiety; Product problem; Drooling; Panting; Shaking; Erythema (f... | Ongoing |
| Jan 10, 2020 | Dog | Bulldog | Afoxolaner | Wound; Dermatitis | Ongoing |
| Jan 10, 2020 | Dog | Shepherd Dog - German | Oclacitinib Maleate | Skin sore; Blood in faeces; Behavioural disorder NOS; Diarrhoea; Vomiting; Fo... | Euthanized |
| Jan 5, 2020 | Dog | Crossbred Canine/dog | Afoxolaner | Scratching; Diarrhoea; Lethargy (see also Central nervous system depression i... | Outcome Unknown |
| Jan 3, 2020 | Dog | American Pit Bull Terrier, ... | Desoxycorticosterone Pivalate | Injection site itching; Wound; Injection site dermatitis; Injection site reac... | Outcome Unknown |
| Jan 3, 2020 | Dog | Lhasa Apso | Milbemycin Oxime; Praziquantel | Generalised red spot; Hot spot (pyotraumatic dermatitis); Erythema (for urtic... | Ongoing |
| Jan 2, 2020 | Cat | Domestic Shorthair | Polymyxin B Sulfate;Oxytetracycline Hcl | Hair loss NOS; Hot spot (pyotraumatic dermatitis); Dermatitis; Pemphigus foli... | Ongoing |
| Jan 2, 2020 | Dog | Shepherd Dog - Australian | Deracoxib | Dermatitis | Outcome Unknown |
| Jan 1, 2020 | Dog | Weimaraner | Milbemycin Oxime; Praziquantel | Dermatitis; Anxiety; Weight loss; Lack of efficacy (bacteria) - Anaplasma; La... | Outcome Unknown |
| Jan 1, 2020 | Dog | Shepherd Dog - Australian | Oclacitinib Maleate | Dermal cyst(s); Pustular skin eruption; Cyst rupture NOS; Skin and/or appenda... | Ongoing |
| Dec 31, 2019 | Dog | Cattle Dog - Australian (bl... | Maropitant Citrate | Squinting; Head shake - behavioural disorder; Skin lump; Barking; Ocular disc... | Ongoing |
| Dec 31, 2019 | Dog | Pit Bull | Imidacloprid; Moxidectin | Lack of efficacy (ectoparasite) - flea; Pruritus; Dry skin; Hot spot (pyotrau... | Outcome Unknown |
| Dec 24, 2019 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site irritation; Lack of efficacy (ectoparasite) - flea; Alopecia... | Recovered/Normal |
| Dec 21, 2019 | Dog | Deutsche Dogge, Great Dane | Robenacoxib | Hives (see also 'Skin'); Ataxia; Lethargy (see also Central nervous system de... | Ongoing |
| Dec 20, 2019 | Dog | Pit Bull, Retriever - Labrador | Unspecified | Pruritus; Hot spot (pyotraumatic dermatitis); Pododermatitis; Excoriation; Li... | Recovered/Normal |
| Dec 19, 2019 | Cat | Siamese, Cat (other) | Selamectin;Sarolaner | Application site alopecia; Alopecia local; Lethargy (see also Central nervous... | Ongoing |
| Dec 18, 2019 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site dermatitis; Application site irritation | Ongoing |
| Dec 14, 2019 | Cat | Domestic Shorthair | Robenacoxib | Injection site hair loss; Injection site pain; Injection site dermatitis | Ongoing |
| Dec 13, 2019 | Dog | Maltese, Dog (unknown) | Moxidectin | Behavioural disorder NOS; Lethargy (see also Central nervous system depressio... | Ongoing |
| Dec 11, 2019 | Dog | Bulldog | Pimobendan | Injection site alopecia; Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Dec 10, 2019 | Cat | Siamese | Selamectin;Sarolaner | Application site alopecia; Moist dermatitis | Outcome Unknown |
| Dec 10, 2019 | Dog | Corgi (unspecified) | Oclacitinib Maleate | Death by euthanasia; Skin lesion NOS; Lymphoma; Ulcerative dermatitis; Pyoder... | Euthanized |
| Dec 3, 2019 | Dog | Bulldog | Rabacfosadine | Limping; Injection site swelling; Injection site erythema; Injection site com... | Ongoing |
| Dec 3, 2019 | Dog | Terrier (unspecified), Dog ... | Oclacitinib Maleate | Dermatitis; Bacterial skin infection NOS | Ongoing |
| Dec 1, 2019 | Dog | Shih Tzu | Lotilaner | Vomiting; Allergic dermatitis | Outcome Unknown |
| Dec 1, 2019 | Cat | Ragdoll | Selamectin;Sarolaner | Papule; Bacterial skin infection NOS; Allergic dermatitis | Ongoing |
| Nov 23, 2019 | Dog | Shepherd Dog - German | Levothyroxine Sodium | Moist dermatitis; Licking | Outcome Unknown |
| Nov 23, 2019 | Dog | Bulldog, Dog (unknown) | Oclacitinib Maleate | Dermatitis; Other immune system disorder NOS; Bacterial skin infection NOS | Outcome Unknown |
| Nov 21, 2019 | Dog | Terrier - Boston | Rabacfosadine | Ear pruritus; Death by euthanasia; Lethargy (see also Central nervous system ... | Euthanized |
| Nov 21, 2019 | Dog | Bichon Frise | Neomycin Sulfate;Tetracaine Hydrochlo... | Skin lump; Claw / hoof / nail disorder NOS; Moist dermatitis; Skin ulcer; Pru... | Ongoing |
| Nov 21, 2019 | Dog | Great Pyrenees | Melarsomine Dihydrochloride | Injection site dermatitis | Recovered/Normal |
| Nov 21, 2019 | Cattle | Cattle (unknown) | Monensin Sodium | Bronchopneumonia; Dermatitis; Death; Reduced growth rate | Ongoing; Died |
| Nov 20, 2019 | Dog | Crossbred Canine/dog, Shih Tzu | Fluralaner Chew Tablets | Dermatitis; Anorexia; Decreased packed cell volume (PCV); Leucocytosis NOS; L... | Euthanized |
| Nov 19, 2019 | Dog | Retriever - Golden, Dog (un... | Cefpodoxime Proxetil | Vesicular rash; Contact dermatitis; Abnormal cytology | Ongoing |
| Nov 19, 2019 | Dog | Dog (unknown) | Carprofen | Perivascular dermatitis; Skin oedema; Skin textural change; Pustules | Recovered/Normal |
| Nov 18, 2019 | Human | Unknown | Afoxolaner | Dermatitis; Blistering (see also Application site SOC) | Recovered/Normal |
| Nov 16, 2019 | Dog | Pit Bull, Dog (unknown) | Afoxolaner | Hives (see also 'Skin'); Blistering (see also Application site SOC); Hot spot... | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.